Clinical Research Site

Phoenix, Arizona 85054

1 studies enrolling now · 13 studies all time

What they study most

Agitation in Patients With Dementia of the Alzheimer's Type, Cataplexy, Chronic Obstructive Pulmonary Disease, Depression, Essential Hypertension, Excessive Daytime Sleepiness, Fibromyalgia, Major Depressive Disorder, Migraine, Narcolepsy, Psoriatic Arthritis, Pulmonary Aspergillosis

Studies at this site

• Fibromyalgia Response With Esreboxetine Evaluated Using a Randomized Withdrawal Research Design — Recruiting now
• A Study to Assess the Efficacy and Safety of AXS-12 (Reboxetine) in Patients With Narcolepsy — Completed
• An Open-label Safety Study of PC945 (Opelconazole) Prophylaxis or Pre-emptive Therapy Against Pulmonary Aspergillosis in Lung Transplant Recipients (OPERA-S Study) — Completed
• A Study to Assess the Long-term Efficacy and Safety of AXS-12 (Reboxetine) in Subjects With Narcolepsy (ENCORE) — Completed
• Psoriatic Arthritis Study of Izokibep — Stopped early
• Phase 2b Pivotal Study of Izokibep in Non-infectious, Intermediate-, Posterior- or Pan-uveitis — Stopped early
• Multimechanistic Treatment Over Time of Migraine Symptoms (MOVEMENT) — Completed
• Maximizing Outcomes in Treating Acute Migraine — Completed
• Efficacy, Safety and Tolerability of AVP-786 for the Treatment of Agitation in Patients With Dementia of the Alzheimer's Type — Completed
• Open-Label Safety Study of AXS-05 in Subjects With Depression — Completed
• A Trial of AXS-05 in Patients With Major Depressive Disorder — Completed
• An Integrated Assessment of the Safety and Effectiveness of Bexagliflozin for the Management of Essential Hypertension — Completed
• Study in Subjects Greater Than 40 Years of Age With COPD — Completed